Lp-PLA2 inhibitory activities of fatty acid glycerols isolated from Saururus chinensis roots

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 15, 2005, Pages 3573-3575

  Woo, Song Lee ^a,b   Mi, Jeong Kim ^a   Beck, Young Il ^a   Park, Yong Dae ^a,b   Jeong, Tae Sook ^a,b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

Author keywords

Fatty acid glycerols; Lp PLA2 inhibitor; Saururus chinensis

Indexed keywords

ACETIC ACID ETHYL ESTER; FATTY ACID DERIVATIVE; GLYCEROL DERIVATIVE; GLYCEROL MONOLINOLEATE; GLYCEROL STEARATE; HERBACEOUS AGENT; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; SAURURUS CHINENSIS EXTRACT; UNCLASSIFIED DRUG; ACYLGLYCEROL; GLYCEROL LINOLEATE; LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A(2); LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A(2); PHOSPHOLIPASE A;

ARTICLE; DRUG ACTIVITY; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; IC 50; MEDICINAL PLANT; PLANT ROOT; SAURURUS CHINENSIS; STRUCTURE ACTIVITY RELATION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; ISOLATION AND PURIFICATION; METABOLISM; SAURURACEAE;

SAURURUS CHINENSIS;

GLYCERIDES; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; PHOSPHOLIPASES A; PLANT ROOTS; PLANTS, MEDICINAL; SAURURACEAE;

EID: 21744432163     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.05.056     Document Type: Article

References (20)

1. D.M. Stafforini, M.R. Elstad, T.M. Mclntyre, G.A. Zimmerman, and S.M. Prescott J. Biol. Chem. 265 1990 9682
2. K. Nakajima, M. Murakami, R. Yanoshita, Y. Samejima, K. Karasawa, M. Setaka, S. Nojima, and I. Kudo J. Biol. Chem. 272 1997 19708
3. K. Asano, S. Okamoto, K. Fukunaga, T. Shiomi, T. Mori, M. Iwata, Y. Ikeda, and K. Yamaguchi Biochem. Biophys. Res. Commun. 261 1999 511
4. M.J. Caslake, C.J. Packard, K.E. Suckling, S.D. Holmes, P. Chamberlain, and C.H. Macphee Atherosclerosis 150 2000 413
5. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witztum N. Engl. J. Med. 320 1989 915
6. C.H. Macphee, K.E. Moores, H.F. Boyd, D. Dhanak, R.J. Ife, C.A. Leach, D.S. Leake, K.J. Milliner, R.A. Patterson, K.E. Suckling, D.G. Tew, and D.M.B. Hickey Biochem. J. 338 1999 479
7. C.A. Leach, D.M.B. Hickey, R.J. Ife, C.H. Macphee, S.A. Smith, and D.G. Tew Il Farmaco 56 2001 45
8. J.A. Blackie, J.C. Bloomer, M.J.B. Brown, H.Y. Cheng, B. Hammond, D.M.B. Hickey, R.J. Ife, C.A. Leach, V.A. Lewis, C.H. Macphee, K.J. Milliner, K.E. Moores, I.L. Pinto, S.A. Smith, I.G. Stansfield, S.J. Stanway, M.A. Taylor, and C. Theobald J. Bioorg. Med. Chem. Lett. 13 2003 1607 and therein cited references.
9. J. Thirkettle, E. Alvarez, H. Boyd, M. Brown, E. Diez, J. Hueso, S. Elson, M. Fulston, C. Gershater, M.L. Morata, P. Perez, S. Ready, J.M. Sanchez-Puelles, R. Sheridan, A. Stefanska, and S. Warr J. Antibiot. 53 2000 664
10. D.J. Busby, R.C. Copley, J.A. Hueso, S.A. Readshaw, and A. Rivera J. Antibiot. 53 2000 670
11. J. Thirkettle J. Antibiot. 53 2000 733
12. H. Yu, D.E. Sok, and T.S. Jeong Kor J. Pharmacogn. 34 2003 100
13. 2CO (95:5, 1 L; 9:1, 1 L; 85:15, 1 L; 80:20, 1 L, 75:25, 1 L) to obtain five fractions. The active fraction 5 (1.5 g) was purified by reverse-phase column chromatography (ODS-A, RP-18; 70-230 mesh; YMC-Gel), eluting successively with an isocratic of aqueous MeOH (90%) to produce compound 4 (3.7 mg) as a colorless oil and compound 5 (6.2 mg) as a white powder.
14. E. Okayama, T. Hasegawa, T. Matsushita, H. Fujimoto, M. Ishibashi, and M. Yamazaki Chem. Pharm. Bull. 49 2001 154
15. R. Katoch, G.K. Trivedi, and R.S. Phadke Bioorg. Med. Chem. 7 1999 2753
16. S. Nakane, T. Tanaka, K. Satouchi, Y. Kobayashi, K. Waku, and T. Sugiura Biol. Pharm. Bull. 23 2000 758
17. T.S. Jeong, M.J. Kim, H. Yu, K.S. Kim, J.K. Choi, S.S. Kim, and W.S. Lee Bioorg. Med. Chem. Lett. 15 2005 1525 and references cited therein
18. J. Bassaganya-riera, R. Hontecillas, and D.C. Beitz Clin. Nutr. 21 2002 451
19. N.L. Kisun, K. David, and W.P. Michael Atherosclerosis 108 1994 19
20. Ghafoorunissa, A. Vani, R. Laxmi, and B. Sesikeran Lipids 37 2002 1077